A pancancer analysis of impact of MDM2/MDM4 on immune checkpoint blockade (ICB). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results